Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephanie Laer"'
Autor:
Muhammad Faisal, Willi Cawello, Bjoern B. Burckhardt, Jan de Hoon, Stephanie Laer, LENA Consortium
Publikováno v:
Frontiers in Pediatrics, Vol 7 (2019)
Enalapril is recommended as the first line of therapy and is proven to improve survival rates for treatment of Pediatric Heart Failure; however, an approved drug and child appropriate dosage formulation is still absent. The present analysis was condu
Externí odkaz:
https://doaj.org/article/8a63134b5d524c8e93bb47088beac1b1
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 13, Pp 481-490 (2019)
Muhammad Faisal,* Willi Cawello,* Bjoern B Burckhardt, Stephanie Laer On behalf of LENA Consortium Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany *These authors contributed equally to t
Externí odkaz:
https://doaj.org/article/a184d1a090034d5e8aa30d4b795882d3
Publikováno v:
Clinical Trials Week; 1/22/2024, p291-291, 1p
Autor:
Nir, Amiram, Lindinger, Angelika, Rauh, Manfred, Bar-Oz, Benjamin, Laer, Stephanie, Schwachtgen, Lynn, Koch, Andreas, Falkenberg, Jan, Mir, Thomas S.
Publikováno v:
Pediatric Cardiology; Jan2009, Vol. 30 Issue 1, p3-8, 6p, 1 Chart, 3 Graphs
Autor:
Faisal, Muhammad, Cawello, Willi, Burckhardt, Bjoern B, Laer, Stephanie, de Hoon, Jan, van Hecken, Anne, Herbort, Marissa, Breitkreutz, Joerg, Wiedey, Wolfgang, Klingmann, Ingrid, Spatenkova, Lucie, Lagler, Florian, Moder, Angelika, Khalil, Feras
Publikováno v:
Drug Design, Development and Therapy
Muhammad Faisal,* Willi Cawello,* Bjoern B Burckhardt, Stephanie Laer On behalf of LENA Consortium Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany *These authors contributed equally to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79fda62de0ca9df54831352884999018
https://lirias.kuleuven.be/handle/123456789/634473
https://lirias.kuleuven.be/handle/123456789/634473
According to the World Health Report (2000 http:/ /www. who. int/whr), of the 55 million deaths worldwide in 1999, more than 16 million were secondary to car diovascular complications. With the prospect of world population increasing from the curre